The Eastern Ontario Health Unit is advising a new treatment is now available in the region to help protect infants from the ...
Researchers from Brigham and Women’s Hospital published new research in Science Translational Medicine showing that natural ...
Starting next month, hospitals will be required by CMS to report their overall bed capacity as well as their census of ...
New data to be shared on GSK’s RSV vaccine across different age groups of patients at increased risk • Efficacy data for gepotidacin in ...
Colorado's health department is working to get more information out to the public about circulating respiratory viruses. It’s ...
Ziresovir, an antiviral drug targeted at respiratory syncytial virus (RSV), was superior to placebo in reducing signs and ...
Clinician-scientists from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, and Boston Children’s Hospital analyzed samples from patients’ airways and ...
Hosted on MSN4d
What It’s Like to Have RSV as an Older AdultAREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted ... You are encouraged to report vaccine adverse events to the US Department of Health and Human Services. Visit www.vaers.hhs.gov to file a ...
EDP-323 is an investigational inhibitor of Respiratory Syncytial Virus (RSV), currently showing promising results in Phase 2a ...
Population Services International and the Elizabeth Glaser Pediatric AIDS Foundation partner up under HealthX Partners to ...
As cold and flu season approaches, The Ad Council, American Medical Association (AMA), Centers for Disease Control and Prevention (CDC), an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback